Sanofi is making significant strides in the fight against chlamydia, the most common sexually transmitted bacterial infection, for which there are currently no approved preventative vaccines. The French pharmaceutical group has recently been granted a fast-track...
Turn Biotechnologies, a startup focused on mRNA therapies for cellular rejuvenation, has acquired an experimental drug delivery technology from Harvard University and Vesigen Therapeutics, according to an exclusive report by Endpoints News. The acquired technology,...
Verve Therapeutics has received clearance from the U.S. Food and Drug Administration (FDA) to expand its ongoing clinical trial of VERVE-102, an experimental gene editing therapy aimed at lowering cholesterol and reducing the risk of heart disease, the company...
Introduction of a Universal Coronavirus Vaccine: A robust cross-immunity effect to combat virus mutations. SEOUL, South Korea, Jan. 8, 2025 /PRNewswire/ — The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The...
LAS VEGAS, Dec. 10, 2024 /PRNewswire/ — The veterinary vaccines market is experiencing robust growth driven by factors such as the rising prevalence of zoonotic diseases, increasing concerns about antimicrobial resistance in animals, and a growing demand for...
